ReviewFrontiers in oncology2026

Innovative use of therapeutic antibodies in lung cancer: the current landscape of ADCs and other antibody-based therapies.

Matthew Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.